EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mineralocorticoid Receptor Antagonists for Preventing Chronic Kidney Disease Progression: Current Evidence and Future Challenges

Wataru Fujii iD, Shigeru Shibata iD

International Journal of Molecular Sciences · 23.04.2023 · 24 (9) · 7719

DOI: 10.3390/ijms24097719 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.04.2023. Verfasst von Wataru Fujii und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Graduate School of Medicine, Teikyo University, Tokyo 173-8605, Japan. Hauptthemen laut MEDLINE: Mineralocorticoid Receptor Antagonists, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulation and action of the mineralocorticoid receptor (MR) have been the focus of intensive research over the past 80 years. Genetic and physiological/biochemical analysis revealed how MR and the steroid hormone aldosterone integrate the responses of distinct tubular cells in the face of environmental perturbations and how their dysregulation compromises fluid homeostasis. In addition to these roles, the accumulation of data also provided unequivocal evidence that MR is involved in the pathophysiology of kidney diseases. Experimental studies delineated the diverse pathological consequences of MR overactivity and uncovered the multiple mechanisms that result in enhanced MR signaling. In parallel, clinical studies consistently demonstrated that MR blockade reduces albuminuria in patients with chronic kidney disease. Moreover, recent large-scale clinical studies using finerenone have provided evidence that the non-steroidal MR antagonist can retard the kidney disease progression in diabetic patients. In this article, we review experimental data demonstrating the critical importance of MR in mediating renal injury as well as clinical studies providing evidence on the renoprotective effects of MR blockade. We also discuss areas of future investigation, which include the benefit of non-steroidal MR antagonists in non-diabetic kidney disease patients, the identification of surrogate markers for MR signaling in the kidney, and the search for key downstream mediators whereby MR blockade confers renoprotection. Insights into these questions would help maximize the benefit of MR blockade in subjects with kidney diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mineralocorticoid Receptor AntagonistsRenal Insufficiency, ChronicHumansAlbuminuriaAldosteroneKidneyReceptors, Mineralocorticoid

Stichwörter der Autor:innen

CKDalbuminuriafibrosisglomerular filtration ratemineralocorticoidspodocytevasculature

Substanzen

AldosteroneMineralocorticoid Receptor AntagonistsReceptors, MineralocorticoidNR3C2 protein, human

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, Graduate School of Medicine, Teikyo University, Tokyo 173-8605, Japan.

ORCID-Profile: Wataru Fujii, Shigeru Shibata

Förderung

  • Japan Society for the Promotion of Science
  • JSPS KAKENHI

Zitieren

APA

Fujii, W., & Shibata, S. (2023). Mineralocorticoid Receptor Antagonists for Preventing Chronic Kidney Disease Progression: Current Evidence and Future Challenges. International Journal of Molecular Sciences, 24(9), 7719. https://doi.org/10.3390/ijms24097719

Vancouver

Fujii W, Shibata S. Mineralocorticoid Receptor Antagonists for Preventing Chronic Kidney Disease Progression: Current Evidence and Future Challenges. International Journal of Molecular Sciences. 2023;24(9):7719. doi:10.3390/ijms24097719

BibTeX
@article{Fujii2023,
  author = {Fujii, Wataru and Shibata, Shigeru},
  title = {Mineralocorticoid Receptor Antagonists for Preventing Chronic Kidney Disease Progression: Current Evidence and Future Challenges},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {9},
  pages = {7719},
  doi = {10.3390/ijms24097719}
}
Kostenlos starten →